UNC Chapel Hill
NIH Earmarks $38M for Consortium Studying Polygenic Risk Scores in Diverse Populations
The consortium aims to develop and evaluate methods for calculating polygenic risk scores for specific diseases, particularly for people of different ancestries.
Reveal Genomics plans to have assays available within three years, and is eager to partner with pharmaceutical and diagnostics companies to fulfill its vision.
Core labs remain closed or at reduced operations due to the COVID-19 pandemic, leading to concerns about the state of their businesses when they can reopen.
Researchers Develop CRISPR Method for Dose-Dependent Gene Expression Activation
The system uses chemical epigenetic modifiers to activate the expression of target genes by recruiting an endogenous chromatin-activating machinery.
Anorexia GWAS Yields Risk Loci with Metabolic, Psychiatric Overlap
A large genome-wide association meta-analysis and follow-up analyses revealed eight risk loci involving SNPs previously associated with body traits, metabolism, and psychiatric risk.